Annual Total Liabilities
$54.42 M
-$11.38 M-17.29%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual total liabilities is $54.42 million, with the most recent change of -$11.38 million (-17.29%) on December 31, 2023.
- During the last 3 years, OCX annual total liabilities has risen by +$32.49 million (+148.10%).
- OCX annual total liabilities is now -42.31% below its all-time high of $94.35 million, reached on December 31, 2021.
Performance
OCX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$60.51 M
+$8.49 M+16.32%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly total liabilities is $60.51 million, with the most recent change of +$8.49 million (+16.32%) on September 30, 2024.
- Over the past year, OCX quarterly total liabilities has increased by +$16.48 million (+37.43%).
- OCX quarterly total liabilities is now -35.87% below its all-time high of $94.35 million, reached on December 31, 2021.
Performance
OCX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
OCX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.3% | +37.4% |
| 3 y3 years | +148.1% | -27.1% |
| 5 y5 years | +792.9% | -27.1% |
OCX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.3% | at low | -35.9% | +37.7% |
| 5 y | 5-year | -42.3% | +503.3% | -35.9% | +570.7% |
| alltime | all time | -42.3% | +2251.9% | -35.9% | +2514.7% |
OncoCyte Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $60.51 M(+16.3%) |
| Jun 2024 | - | $52.02 M(-12.4%) |
| Mar 2024 | - | $59.38 M(+9.1%) |
| Dec 2023 | $54.42 M(-17.3%) | $54.42 M(+23.6%) |
| Sep 2023 | - | $44.02 M(+0.2%) |
| Jun 2023 | - | $43.94 M(-2.1%) |
| Mar 2023 | - | $44.87 M(-31.8%) |
| Dec 2022 | $65.80 M(-30.3%) | $65.80 M(-18.2%) |
| Sep 2022 | - | $80.49 M(-3.0%) |
| Jun 2022 | - | $82.95 M(-7.1%) |
| Mar 2022 | - | $89.31 M(-5.3%) |
| Dec 2021 | $94.35 M(+330.1%) | $94.35 M(+36.7%) |
| Sep 2021 | - | $68.99 M(-7.7%) |
| Jun 2021 | - | $74.72 M(+229.5%) |
| Mar 2021 | - | $22.68 M(+3.4%) |
| Dec 2020 | $21.94 M(+143.2%) | $21.94 M(-5.2%) |
| Sep 2020 | - | $23.14 M(-3.0%) |
| Jun 2020 | - | $23.86 M(+4.3%) |
| Mar 2020 | - | $22.88 M(+153.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $9.02 M(+48.0%) | $9.02 M(+162.6%) |
| Sep 2019 | - | $3.44 M(-17.4%) |
| Jun 2019 | - | $4.16 M(+19.2%) |
| Mar 2019 | - | $3.49 M(-42.7%) |
| Dec 2018 | $6.09 M(+4.9%) | $6.09 M(+13.2%) |
| Sep 2018 | - | $5.38 M(+0.6%) |
| Jun 2018 | - | $5.35 M(-18.4%) |
| Mar 2018 | - | $6.56 M(+12.9%) |
| Dec 2017 | $5.81 M(+26.8%) | $5.81 M(-6.3%) |
| Sep 2017 | - | $6.20 M(-4.6%) |
| Jun 2017 | - | $6.50 M(+1.6%) |
| Mar 2017 | - | $6.40 M(+39.6%) |
| Dec 2016 | $4.58 M(+98.1%) | $4.58 M(+9.7%) |
| Sep 2016 | - | $4.18 M(+41.3%) |
| Jun 2016 | - | $2.96 M(+7.4%) |
| Mar 2016 | - | $2.75 M(+18.9%) |
| Dec 2015 | $2.31 M(-63.4%) | $2.31 M(-56.8%) |
| Sep 2015 | - | $5.36 M(-15.2%) |
| Dec 2014 | $6.32 M(+35.2%) | $6.32 M |
| Dec 2013 | $4.67 M | - |
FAQ
- What is OncoCyte annual total liabilities?
- What is the all time high annual total liabilities for OncoCyte?
- What is OncoCyte annual total liabilities year-on-year change?
- What is OncoCyte quarterly total liabilities?
- What is the all time high quarterly total liabilities for OncoCyte?
- What is OncoCyte quarterly total liabilities year-on-year change?
What is OncoCyte annual total liabilities?
The current annual total liabilities of OCX is $54.42 M
What is the all time high annual total liabilities for OncoCyte?
OncoCyte all-time high annual total liabilities is $94.35 M
What is OncoCyte annual total liabilities year-on-year change?
Over the past year, OCX annual total liabilities has changed by -$11.38 M (-17.29%)
What is OncoCyte quarterly total liabilities?
The current quarterly total liabilities of OCX is $60.51 M
What is the all time high quarterly total liabilities for OncoCyte?
OncoCyte all-time high quarterly total liabilities is $94.35 M
What is OncoCyte quarterly total liabilities year-on-year change?
Over the past year, OCX quarterly total liabilities has changed by +$16.48 M (+37.43%)